Immunochemical variants of HLA-B27.
Detailed study of HLA-B27 was prompted by the extremely strong associations between this antigen and spondyloarthropathies. Despite the relative homogeneity of this antigen when defined by alloantisera, B27 reactivity with the monoclonal antibody B27M2 suggests previously unrecognized heterogeneity. To define and confirm this heterogeneity on a molecular level, detergent extracts were prepared from B cell lines derived from individuals reactive (+) or unreactive (-) with the B27M2 antibody. Extracts were immunoprecipitated by specific allogeneic or monoclonal antibodies and analyzed by two-dimensional polyacrylamide gel electrophoresis. By this method the B27M2+ and B27M2- variants of HLA-B27 had different isoelectric points (pl) and could be distinguished from each other and from a different (Bw44) control alloantigen. Blockade of glycosylation by pretreatment of cells with tunicamycin did not alter pl but did reduce HLA antigens by approximately 3000 daltons. These data demonstrate that B27 antigens can be subdivided into subsets with different molecular composition. The effects of this heterogeneity upon the associations of B27 and disease are not yet known.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D011232:Chemical Precipitation; D004591:Electrophoresis, Polyacrylamide Gel; D014644:Genetic Variation; D006680:HLA Antigens / Q000032:analysis / Q000235:genetics* / Q000276:immunology; D015796:HLA-B27 Antigen; D006801:Humans; D007518:Isoantibodies / Q000276:immunology; D051379:Mice; D013167:Spondylitis, Ankylosing / Q000235:genetics / Q000276:immunology
D000911:Antibodies, Monoclonal; D006680:HLA Antigens; D015796:HLA-B27 Antigen; D007518:Isoantibodies